未登录

F

Friedl Sinnaeve

KU Leuven

H指数:9

被引数:420

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours

JOURNAL OF PATHOLOGY CLINICAL RESEARCH

IF3.7

2024-05-131

OAAI

Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes

JOURNAL OF MOLECULAR DIAGNOSTICS

IF3.4

2024-05-017

OAAI

XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) and their histopathological and molecular characterization

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

MOLECULAR CANCER THERAPEUTICS

IF5.5

2019-06-0328

OAAI

XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS)-an update on a preclinical platform for early drug testing

CANCER RESEARCH

IF16.6

2018-07-010

PRE

XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS), an update on a preclinical platform for early drug testing

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS): a preclinical plafform for early drug testing

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Establishment and characterization of a panel of patient-derived soft tissue sarcoma (STS) xenograft models for in vivo testing of novel therapeutic approaches

CANCER RESEARCH

IF16.6

2015-08-010

PRE

ESTABLISHMENT AND CHARACTERIZATION OF A PANEL OF PATIENT-DERIVED SOFT TISSUE SARCOMA (STS) XENOGRAFT MODELS FOR IN VIVO TESTING OF NOVEL THERAPEUTIC APPROACHES

ANNALS OF ONCOLOGY

IF65.4

2014-09-010

OAAI

1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

IF7.3

2011-08-0872

OA